Clinical Trial Update: Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety and tolerability of Lu AF11167 after repeated dosing in patients with schizophrenia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Lu AF11167

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED